On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapies

Steffen Unkel, Marjan Amiri, Norbert Benda +14

The analysis of adverse events (AEs) is a key component in the assessment of a drug's safety profile. Inappropriate analysis methods may result in misleading conclusions about a th…